BRIEF published on 03/12/2025 at 18:05, 11 days 22 hours ago COFIDUR Engaged in Discussions with Eolane Partnership Collaboration Discussions COFIDUR Eolane
BRIEF published on 03/12/2025 at 18:05, 11 days 22 hours ago COFIDUR Engagée dans des Discussions avec Eolane Partenariat Collaboration Discussions COFIDUR Eolane
PRESS RELEASE published on 03/12/2025 at 18:00, 11 days 22 hours ago Communiqué-suite-discussion-avec-Eolane
BRIEF published on 03/05/2025 at 18:05, 18 days 22 hours ago COFIDUR : Mise à jour du nombre d'actions et de droits de vote Droits De Vote Capital Social Actions Investisseurs COFIDUR
BRIEF published on 03/05/2025 at 18:05, 18 days 22 hours ago COFIDUR: Update of the number of shares and voting rights Share Capital Voting Rights Investors Actions COFIDUR
PRESS RELEASE published on 03/05/2025 at 18:00, 18 days 22 hours ago Nombre total d'actions et de droit de vote au 28 février 2025 Nombre total d'actions et de droit de vote au 28 février 2025 Actions Droit De Vote 28 Février 2025
BRIEF published on 02/21/2025 at 18:05, 1 month 2 days ago COFIDUR : Confirmation de Déclaration d'Intérêt Croissance Actionnaires Développement Stratégique COFIDUR Déclaration D'intérêt
BRIEF published on 02/21/2025 at 18:05, 1 month 2 days ago COFIDUR: Confirmation of Declaration of Interest Shareholders Strategic Development Growth COFIDUR Declaration Of Interest
PRESS RELEASE published on 02/21/2025 at 18:00, 1 month 2 days ago Communiqué de Confirmation de déclaration d'intérêt
BRIEF published on 02/05/2025 at 12:05, 1 month 19 days ago COFIDUR Announces its Eligibility for the PEA PME 2025 Investment Growth PEA SME 2025 COFIDUR
Published on 03/24/2025 at 14:20, 2 hours 9 minutes ago MicroVision Announces Appointment of Industry Veteran as CTO
Published on 03/24/2025 at 14:00, 2 hours 29 minutes ago DEXIS to Showcase Cutting-Edge Innovations at IDS 2025
Published on 03/24/2025 at 13:00, 3 hours 29 minutes ago Tharimmune Announces Positive Results for Novel Oral Monoclonal Antibody TH023 Targeting Tumor Necrosis Factor-alpha
Published on 03/24/2025 at 12:30, 3 hours 59 minutes ago MIRA Pharmaceuticals Signs Binding Letter of Intent to Acquire SKNY Pharmaceuticals, Securing a $5 Million Capital Infusion to Advance Weight Loss and Smoking Cessation Drug Development
Published on 03/24/2025 at 12:30, 3 hours 59 minutes ago Stillwater Critical Minerals Welcomes Executive Order to Prioritize and Accelerate Domestic Mining and Mineral Production in the United States of America
Published on 03/24/2025 at 16:10, 19 minutes ago EQS-Adhoc: Allgeier SE: Allgeier achieves its 2024 earnings guidance
Published on 03/24/2025 at 15:56, 32 minutes ago EQS-Adhoc: Vectron Systems AG: Agreement on Severance and Compensation Payment between Vectron and Shift4 Group under the domination and profit and loss transfer agreement
Published on 03/24/2025 at 15:07, 1 hour 21 minutes ago Galimedix Therapeutics to present positive pre-clinical data with amyloid beta aggregation modulator in development for oral Alzheimer’s disease treatment at AD/PD™ 2025 Conference
Published on 03/24/2025 at 14:26, 2 hours 3 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 03/24/2025 at 09:30, 6 hours 58 minutes ago Release of the Universal Registration Document including the Annual Financial Report as of December 31, 2024
Published on 03/24/2025 at 09:28, 7 hours 1 minute ago Communiqué de mise à disposition du Document d'Enregistrement Universel incluant le Rapport Financier Annuel au 31 décembre 2024
Published on 03/24/2025 at 08:30, 7 hours 59 minutes ago EURAZEO PRÉVOIT D'INVESTIR 100 MILLIONS D'EUROS AVEC METROBLOKS POUR SOUTENIR L'EXPANSION DE DATA CENTERS DE NOUVELLE GÉNÉRATION EN EUROPE
Published on 03/24/2025 at 08:30, 7 hours 59 minutes ago EURAZEO PLANS TO INVEST €100 MILLION WITH METROBLOKS TO SUPPORT EXPANSION OF NEXT-GENERATION DATA CENTERS IN EUROPE
Published on 03/24/2025 at 07:30, 8 hours 59 minutes ago Biophytis annonce de nouvelles données non cliniques renforçant sa mission de pionnier dans la restauration de la mobilité chez les patients souffrant d’obésité.
